×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
山东大学 [4]
复旦大学上海医学院 [3]
中国医学科学院 北京... [3]
四川大学 [1]
中南大学 [1]
河北大学 [1]
更多...
内容类型
期刊论文 [15]
发表日期
2018 [4]
2017 [3]
2016 [1]
2015 [3]
2014 [1]
2013 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共15条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:
Hua, Jie
;
Shi, Si
;
Liang, Dingkong
;
Liang, Chen
;
Meng, Qingcai
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
pancreatic cancer
second-line
chemotherapy
targeted therapy
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer
期刊论文
THORACIC CANCER, 2018, 卷号: 9, 期号: 9
作者:
Lv, Chunxin
;
Liu, Xiuju
;
Zheng, Qiwen
;
Chen, Hanxiao
;
Yang, Xue
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2019/12/05
Second-line chemotherapy
small cell lung cancer
topoisomerase-1
topotecan
Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial
期刊论文
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 卷号: Vol.20 No.6, 页码: 768-774
作者:
Zhou, K.
;
Wen, F.
;
Zhang, P.
;
Zhou, J.
;
Zheng, H.
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/02/28
Cost-effectiveness
Sensitive
relapsed
smallcell
lung
cancer
Cisplatin
plus
etoposide
plus
irinotecan
Topotecan
Second-line
chemotherapy
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer
期刊论文
2018, 卷号: 9, 期号: 9, 页码: 1166-1173
作者:
Lv, Chunxin
;
Liu, Xiuju
;
Zheng, Qiwen
;
Chen, Hanxiao
;
Yang, Xue
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/01/03
Second-line chemotherapy
small cell lung cancer
topoisomerase-1
topotecan
S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials
期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 30
作者:
Zhong, Sheng
;
Qie, Shuai
;
Yang, Liu
;
Yan, Qi
;
Ge, Linna
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
advanced pancreatic cancer
combination therapy
irinotecan
leucovorin
monotherapy
oxaliplatin
S-1
second-line chemotherapy
Efficacy and safety of Endostar (recombinant human endostatin hormone) combined with docetaxel as second-or third-line therapy for patients with non-small-cell lung cancer
期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 卷号: 10, 期号: 1
作者:
Ji, Dongmei
;
Wang, Jialei
;
Yu, Hui
;
Wu, Xianghua
;
Wang, Huijie
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
Carcinoma
non-small-cell lung
chemotherapy
second or third line therapy
endostar protein
docetaxel
Efficacy and Safety of Nab-Paclitaxel as Second-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer
期刊论文
ANTICANCER RESEARCH, 2017, 卷号: 37, 期号: 8, 页码: 4687-4691
作者:
Wong, Wenjing
;
Sun, Ping
;
Mu, Zhengbin
;
Liu, Jiannan
;
Yu, Caiyan
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/12
NSCLC
nab-paclitaxel
chemotherapy
second-line
Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy
期刊论文
ONCOLOGY RESEARCH, 2016, 卷号: 24, 期号: 2, 页码: 129-135
作者:
Wang, Yue-shen
;
Tian, Jing
;
Han, Yong
;
Han, Shu-mei
;
Shi, Sheng-bin
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/16
Advanced esophageal cancer
Second-line treatment
Gemcitabine plus
vinorelbine
Platinum-based chemotherapy
miRNA-214
Progression-free
survival
A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer
期刊论文
MEDICAL ONCOLOGY, 2015, 卷号: 32, 期号: 1
作者:
Cao, Ranhua
;
Zhang, Shuai
;
Ma, Dedong
;
Hu, Likuan
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/17
Chinese metastatic colorectal cancer
Second-line chemotherapy
FOLFIRI
Bevacizumab
A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer
期刊论文
Medical oncology, 2015, 期号: 1
作者:
Cao, Ranhua
;
Zhang, Shuai
;
Ma, Dedong
;
Hu, Likuan
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/17
Chinese metastatic colorectal cancer
Second-line chemotherapy
FOLFIRI
Bevacizumab
©版权所有 ©2017 CSpace - Powered by
CSpace